Dashboard
Manage Tickers

CRDLCardiol Therapeutics Inc.

Nasdaq cardiolrx.com


$ 2.28 $ -0.21 (-8.47 %)    

Monday, 16-Sep-2024 15:59:46 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 2.27
$ 2.27 x 1,100
-- x --
-- - --
$ 0.66 - $ 3.12
423,692
na
148.35M
$ 1.52
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cardiol-therapeutics-concludes-maveric-phase-ii-study-on-recurrent-pericarditis-with-findings-to-be-presented-at-the-2024-american-heart-association-scientific-sessions
Cardiol Therapeutics Concludes MAvERIC Pha...
09/10/2024 11:33:01

roth-mkm-initiates-coverage-on-cardiol-therapeutics-with-buy-rating-announces-price-target-of-10
Roth MKM Initiates Coverage On Cardiol The...
06/26/2024 12:46:19

Roth MKM analyst Jason Wittes initiates coverage on Cardiol Therapeutics (NASDAQ:CRDL) with a Buy rating and announces Price...

hc-wainwright--co-reiterates-buy-on-cardiol-therapeutics-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Card...
06/14/2024 10:05:28

HC Wainwright & Co. analyst Vernon Bernardino reiterates Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and maintains $9 ...

Core News & Articles
Cardiol Therapeutics Presented Topline Dat...
06/13/2024 12:01:55

Administration of CardiolRx™ led to a marked reduction in the primary efficacy endpoint of pericarditis painCardiolRx™ also sho...

hc-wainwright--co-reiterates-buy-on-cardiol-therapeutics-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Card...
06/07/2024 11:01:07

HC Wainwright & Co. analyst Vernon Bernardino reiterates Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and maintains $9 ...

canaccord-genuity-maintains-buy-on-cardiol-therapeutics-raises-price-target-to-8
Canaccord Genuity Maintains Buy on Cardiol...
05/23/2024 11:57:56

Canaccord Genuity analyst Edward Nash maintains Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and raises the price target fr...

hc-wainwright--co-reiterates-buy-on-cardiol-therapeutics-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Card...
05/14/2024 15:00:05

HC Wainwright & Co. analyst Vernon Bernardino reiterates Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and maintains $9 ...

hc-wainwright--co-initiates-coverage-on-cardiol-therapeutics-with-buy-rating-announces-price-target-of-9
HC Wainwright & Co. Initiates Coverage On ...
04/22/2024 10:08:41

HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on Cardiol Therapeutics (NASDAQ:CRDL) with a Buy rating...

cardiol-therapeutics-q4-eps-009-beats-012-estimate
Cardiol Therapeutics Q4 EPS $(0.09) Beats ...
04/02/2024 12:13:15

Cardiol Therapeutics (NASDAQ:CRDL) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of ...

cardiol-therapeutics-cash-and-cash-equivalents-of-349m-as-of-december-31-2023-which-funds-operations-into-2026
Cardiol Therapeutics' Cash And Cash Equiva...
04/02/2024 10:39:13

cardiol-therapeutics-says-fda-granted-orphan-drug-designation-for-its-lead-drug-candidate-for-treatment-of-pericarditis
Cardiol Therapeutics Says FDA Granted Orph...
02/15/2024 12:30:49

cardiol-therapeutics-exceeds-50-enrollment-in-phase-ii-archer-trial-in-acute-myocarditis
Cardiol Therapeutics Exceeds 50% Enrollmen...
01/09/2024 12:30:00

cbd-to-treat-heart-failure-new-study-shows-its-cardioprotective-effects
CBD To Treat Heart Failure? New Study Show...
10/10/2023 16:57:03

On Tuesday, Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) announced positive study results demonstrating that subcutaneo...

why-murphy-canyon-acquisition-shares-are-trading-higher-by-around-32-here-are-20-stocks-moving-premarket
Why Murphy Canyon Acquisition Shares Are T...
09/21/2023 11:51:35

Gainers Near Intelligence, Inc. (NASDAQ: NIR) shares rose 34.1% to $0.2801 in pre-market trading after falling 42% on Wednesda...

cardiol-therapeutics-announces-all-collaborating-clinical-research-centers-now-initiated-and-eligible-to-enroll-patients-in-archer-a-phase-ii-trial-of-cardiolrx-for-treatment-of-acute-myocarditis
Cardiol Therapeutics Announces All Collabo...
09/19/2023 11:29:01

cantor-fitzgerald-reiterates-overweight-on-cardiol-therapeutics-maintains-3-price-target
Cantor Fitzgerald Reiterates Overweight on...
08/14/2023 12:53:23

Cantor Fitzgerald analyst Charles Duncan reiterates Cardiol Therapeutics (NASDAQ:CRDL) with a Overweight and maintains $3 pr...

canaccord-genuity-maintains-buy-on-cardiol-therapeutics-raises-price-target-to-6
Canaccord Genuity Maintains Buy on Cardiol...
05/19/2023 11:55:20

Canaccord Genuity analyst Edward Nash maintains Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and raises the price target fr...

reported-earlier-cardiol-therapeutics-says-first-patient-enrolled-in-phase-2-study-of-cardiolrx-for-pericarditis
Reported Earlier, Cardiol Therapeutics Say...
01/17/2023 20:05:22

Cardiol Therapeutics CEO David Elsley shared news the company has hit a major milestone in that the first patient has been enro...

Core News & Articles
Cardiol Therapeutics Receives Nasdaq Defic...
11/14/2022 22:17:02

Oakville, Ontario--(Newsfile Corp. - November 14, 2022) - Cardiol Therapeutics Inc. (NASDAQ:CRDL) (TSX:CRDL) ("Cardiol"...

stocks-that-hit-52-week-lows-on-friday
Stocks That Hit 52-Week Lows On Friday
10/21/2022 17:26:19

  On Friday morning, 446 companies hit new 52-week lows.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION